CST
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 27 Nov 2023)
What this means for you
Registered since 29 Nov 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 85668482
- Registration number
- 5091362
- Mark type
- Stylized text
- Filed
- 03 Jul 2012
- Published for opposition
- 04 Dec 2012
- Registered
- 29 Nov 2016
- Attorney of record
- Keith A. Weltsch, Esq.
Goods and services
- Class 001 — Chemicals: Antibodies, enzymes and nucleic acids for scientific and research use; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry, and microbiology; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
Owner
- Cell Signaling Technology, Inc., Danvers, MA, US
- Cell Signaling Technology, Inc., Danvers, MA, US
- Cell Signaling Technology, Inc., Danvers, MA, US
Prosecution history
- 29 Nov 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 27 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Nov 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 27 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 May 2023 — TEAS SECTION 8 & 15 RECEIVED
- 08 Mar 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Mar 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Mar 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Nov 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Feb 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Nov 2016 — REGISTERED-PRINCIPAL REGISTER
- 22 Oct 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Oct 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Sept 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Sept 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE